SMP-93566
SMP-93566 is a kind of antibody-drug conjugates (ADCs) with a low payload shedding rate and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3055605-39-2
- Formule: C72H100N8O21
- Masse moléculaire:1413.61
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform Drug-Linker Conjugates for ADC
More
Activité biologique
Description
In Vitro
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 3055605-39-2
-
Masse moléculaire 1413.61
-
Formule C72H100N8O21
-
SMILES
O=C(NC[C@@H](O)C[C@H]1O[C@@H](C[C@H]2O[C@@H](CC[C@H]3C(C[C@H](CC[C@]45C[C@](O6)([H])[C@@H]7O4)O3)=C)C[C@@H](C)C2=C)[C@H](CC(C[C@H]8CC[C@@]9([H])[C@]([C@H](O5)C6C7O9)([H])O8)=O)[C@H]1OC)CNC([C@H](CC%10=CC=CC=C%10)NC(CNC(CNC(CN%11CCOCCN(C(CCN%12C(C=CC%12=O)=O)=O)CCOCC%11)=O)=O)=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Pureté et documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)